NAMS (NewAmsterdam Pharma Company N.V.) Stock Market Reviews

crown

search

Read and share opinions on NAMS (NewAmsterdam Pharma Company N.V.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stoc

NAMS

NewAmsterdam Pharma Company N.V.

clarify Biotechnology

bookmark Healthcare

public Netherlands

Sell Neutral Buy

Latest News

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025
NewAmsterdam Pharma (NAMS) Revenue Forecast to Grow 59.1% Annually, Defying Persistent Losses and Valuation Concerns
Nov 6, 2025
NewAmsterdam Pharma Company N.V. (NAMS) Reports Q3 Loss, Lags Revenue Estimates
Nov 5, 2025
NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in November
Oct 30, 2025
NewAmsterdam Pharma Company N.V. (NAMS) Expected to Beat Earnings Estimates: Should You Buy?
Oct 29, 2025
Examining NewAmsterdam Pharma (NasdaqGM:NAMS) Valuation After Recent Share Price Rally
Oct 26, 2025
Entera Bio to Present New Clinical Data from Phase 2 Trial of EB613 at the 2025 North American Menopause Society (NAMS) Annual Meeting
Oct 16, 2025
NewAmsterdam Pharma Company N.V. (NAMS) Soars 5.9%: Is Further Upside Left in the Stock?
Oct 7, 2025
NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum
Sep 24, 2025
NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in September
Aug 25, 2025
Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania Site
Aug 21, 2025

Reviews